Loading…

A PHASE II STUDY OF THP (PIRARUBICIN)‐COP THERAPY IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED PTCL: THP‐3 STUDY OF JAPAN HEMATOPOIETIC MALIGNANCY CLINICAL STUDY GROUP

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2019-06, Vol.37 (S2), p.468-469
Main Authors:	Ogura, M., Ohmachi, K., Suzuki, R., Atsuta, Y., Ito, T., Ohyashiki, K., Yano, S., Hidaka, M., Ando, K., Fukuhara, N., Morishita, Y., Suzuki, T., Tsukasaki, K., Kobayashi, N., Tsukamoto, K., Ozawa, Y., Yamamoto, K., Hotta, T., Kinoshita, T.
Format:	Article
Language:	English
Subjects:	Blood cancer Malignancy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!